Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-08-03 Sale | 2026-08-04 3:15 pm | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer | 1,900 | $24.92 | $47,348 | 92,562 (Direct) | View |
| 2026-06-15 Sale | 2026-06-15 6:46 pm | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer | 1,899 | $24.62 | $46,753 | 94,462 (Direct) | View |
| 2026-03-06 Sale | 2026-03-10 4:51 pm | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer | 9,526 | $21.87 | $208,312 | 66,820 (Direct) | View |
| 2026-03-02 Sale | 2026-03-03 6:51 pm | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer | 8,135 | $22.8 | $185,478 | 76,346 (Direct) | View |
| 2025-09-12 Sale | 2025-09-12 4:11 pm | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer | 2,450 | $31.17 | $76,367 | 73,271 (Direct) | View |
| 2025-03-12 Sale | 2025-03-14 5:59 pm | Evolus Inc. | EOLS | Parschauer Karah Herdman Director | 12,888 | $12.99 | $167,465 | 32,183 (Direct) | View |
| 2025-03-03 Sale | 2025-03-04 8:18 pm | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer | 12,846 | $42.1 | $540,817 | 75,287 (Direct) | View |
| 2025-02-27 Sale | 2025-03-03 1:58 pm | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer | 2,990 | $42.88 | $128,224 | 95,764 (Direct) | View |
| 2024-06-12 Sale | 2024-06-12 7:47 pm | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer | 9,806 | $45 | $441,270 | 57,981 (Direct) | View |
| 2024-03-01 Sale | 2024-03-05 8:22 pm | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer | 3,756 | $53.76 | $201,923 | 98,740 (Direct) | View |
| 2024-01-30 Sale | 2024-02-02 4:57 pm | Evolus Inc. | EOLS | Parschauer Karah Herdman Director | 11,931 | $13.14 | $156,733 | 31,243 (Direct) | View |
| 2023-05-04 Sale | 2023-05-05 2:16 pm | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer | 4,378 | $45 | $197,010 | 51,982 (Direct) | View |
| 2023-03-01 Sale | 2023-03-03 7:59 pm | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer | 3,161 | $45.25 | $143,035 | 95,539 (Direct) | View |
| 2022-03-07 Sale | 2022-03-08 12:25 pm | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer | 5,140 | $62.95 | $323,563 | 34,438 (Direct) | View |
| 2022-03-01 Sale | 2022-03-03 6:08 pm | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer | 2,886 | $66.62 | $192,265 | 64,478 (Direct) | View |
| 2021-10-14 Sale | 2021-10-18 6:46 pm | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel | 310 | $81.14 | $25,153 | 28,358 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-05-28 Option Award | 2026-05-29 7:09 pm | 2027-05-28 2036-05-27 | Tenaya Therapeutics Inc. | TNYA | Parschauer Karah Herdman Director | 120,000 | $0 | 120,000 (Direct) | View |
| 2026-04-16 Option Award | 2026-04-20 5:15 pm | N/A 2036-04-16 | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer | 78,855 | $0 | 145,675 (Direct) | View |
| 2026-03-01 Option Award | 2026-03-03 6:51 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer | 11,137 | $0 | 76,346 (Direct) | View |
| 2026-02-17 Option Award | 2026-02-19 8:57 pm | N/A N/A | Evolus Inc. | EOLS | Parschauer Karah Herdman Director | 45,559 | $0 | 77,742 (Direct) | View |
| 2025-05-29 Option Award | 2025-05-30 6:48 pm | 2026-05-29 2035-05-28 | Tenaya Therapeutics Inc. | TNYA | Parschauer Karah Herdman Director | 107,400 | $0 | 107,400 (Direct) | View |
| 2025-03-07 Option Award | 2025-03-11 6:53 pm | N/A 2035-03-07 | Evolus Inc. | EOLS | Parschauer Karah Herdman Director | 18,510 | $0 | 56,217 (Direct) | View |
| 2025-03-01 Option Award | 2025-03-04 8:18 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer | 18,443 | $0 | 75,287 (Direct) | View |
| 2025-03-01 Option Award | 2025-03-03 1:58 pm | N/A 2035-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer | 40,568 | $0 | 95,764 (Direct) | View |
| 2024-10-18 Option Award | 2024-10-21 8:39 pm | 2025-05-31 2034-10-17 | Tenaya Therapeutics Inc. | TNYA | Parschauer Karah Herdman Director | 34,000 | $0 | 34,000 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 8:22 pm | N/A 2034-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer | 50,157 | $0 | 98,740 (Direct) | View |
| 2024-02-07 Option Award | 2024-02-09 6:37 pm | N/A 2034-02-07 | Evolus Inc. | EOLS | Parschauer Karah Herdman Director | 15,841 | $0 | 47,084 (Direct) | View |
| 2023-06-09 Option Award | 2023-06-12 8:24 pm | 2024-06-09 2033-06-08 | Tenaya Therapeutics Inc. | TNYA | Parschauer Karah Herdman Director | 29,532 | $0 | 29,532 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 7:59 pm | N/A 2033-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer | 64,063 | $0 | 95,539 (Direct) | View |
| 2023-01-27 Option Award | 2023-01-31 8:41 pm | N/A 2033-01-27 | Evolus Inc. | EOLS | Parschauer Karah Herdman Director | 20,082 | $0 | 54,963 (Direct) | View |
| 2022-04-21 Option Award | 2022-10-03 7:56 pm | N/A 2027-02-28 | Anebulo Pharmaceuticals Inc. | ANEB | Parschauer Karah Herdman Director | 30,425 | $0 | 30,425 (Direct) | View |
| 2022-09-08 Option Award | 2022-09-09 7:25 pm | 2023-09-08 2032-09-07 | Tenaya Therapeutics Inc. | TNYA | Parschauer Karah Herdman Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 6:08 pm | N/A 2032-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer | 38,900 | $0 | 64,478 (Direct) | View |
| 2022-01-24 Option Award | 2022-01-26 9:01 pm | N/A 2032-01-24 | Evolus Inc. | EOLS | Parschauer Karah Herdman Director | 38,295 | $0 | 57,608 (Direct) | View |
| 2021-12-22 Option Award | 2021-12-23 5:58 pm | N/A 2031-12-22 | Tenaya Therapeutics Inc. | TNYA | Parschauer Karah Herdman Director | 19,495 | $0 | 19,495 (Direct) | View |